PNC Financial Services Group’s Dyne Therapeutics DYN Stock Holding History

PNC Financial Services Group’s Portfolio DYN Stock Details DYN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16.7K	Buy	921 +503	+120%	+$8.67K	﹤0.01%	3767
2025 Q4	$8.18K	Sell	418 -42	-9%	-$795	﹤0.01%	4041
2025 Q3	$5.82K	Buy	460 +250	+119%	+$2.85K	﹤0.01%	4143
2025 Q2	$2K	Buy	210 +185	+740%	+$2.04K	﹤0.01%	4409
2025 Q1	$262	Buy	25 +4	+19%	+$57	﹤0.01%	4743
2024 Q4	$495	Sell	21 -119	-85%	-$3.52K	﹤0.01%	4532
2024 Q3	$5.03K	Buy	140 +111	+383%	+$4.42K	﹤0.01%	4036
2024 Q2	$1.02K	Buy	29 +19	+190%	+$552	﹤0.01%	4418
2024 Q1	$284	Buy	+10	New	+$226	﹤0.01%	4565

Other funds holding DYN

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

PNC Financial Services Group's DYN Position: Q1 2026 in Review

PNC Financial Services Group increased its Dyne Therapeutics (DYN) stake by 120% in Q1 2026, buying an estimated $8.67K and bringing the position to 921 shares worth $16.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3767.

PNC Financial Services Group first reported a position in DYN in Q1 2024 and has held it in 9 quarters since. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

PNC Financial Services Group held 921 shares of Dyne Therapeutics worth $16.7K as of Q1 2026.
PNC Financial Services Group bought 503 Dyne Therapeutics shares in Q1 2026, an estimated $8.67K.
Dyne Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #3767 holding.
PNC Financial Services Group first reported a position in Dyne Therapeutics in Q1 2024 and has held it in 9 quarters since.
227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.